Veridien Moves Forward with Expansion of Sales Representative Network
Last update: 8/14/2008 1:09:01 PMNew Supply Chain Resources Enable Access to Revenue Growth from Private Label Opportunities LARGO, Fla., Aug 14, 2008 (BUSINESS WIRE) --
Veridien Corporation (VRDE) announced today that it has expanded its national medical sales representative network to 28 representatives across the United States and Canada. Paul Dunnigan, VP-Marketing Group said, "Veridien trained 21 medical sales representatives in Q1 and Q2. Veridien has recently added and trained seven more representatives in order to expand sales coverage of all North American markets. Our goal is to have approximately 32 representatives by year end 2008, who will cover all of the United States and Canada. "The role of the medical sales network is to focus on and drive sales in our core business. The representatives, through their extensive client base in the medical arena, have started opening doors into acute care markets, nursing homes and independent surgery centers. Viraguard(R) Infection Control products are now in clinical trials in several American hospitals, as well as nursing homes and two new medical supply distributors. These new developments and the efforts of the 28 sales representatives, are expected to impact revenues in late Q3 and Q4, 2008 and beyond. "In alternative markets, Veridien has continued to grow with pandemic planning programs in Canadian markets. Veridien plans to launch this program in US markets in Q4, 2008. As well, Veridien has established a distributor relationship with FDM Marketing to supply Viraguard(R) Infection Control products to university and college athletic facilities, specifically for the purpose of controlling MRSA outbreaks in athletic environments. "The cost of most Viraguard(R) components have been adversely affected by world oil prices. To offset the slow economy and these rising costs, Veridien has aggressively re-adjusted its supply chain to drive down the cost of manufacturing. This has resulted in new manufacturing resources that are enabling Veridien to bid on large private label contracts in the medical industry and the Sanitation and Janitorial industry. These bid programs are expected to create revenue opportunities commencing in Q4, 2008." "Safe Harbor" Statement Under the Private Securities Litigation Reform Act of 1995 Forward-looking statements in this press release (identifiable by such words as "believes", "projects", "expects", "beginning", "intended", "planned") are made pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, market acceptance of, and demand for, the Company's products, manufacturing, development and distributor issues, product pricing, competition, funding availability, technological changes and other risks not identified herein. The Company disclaims any intent or obligation to update any forward-looking statements. About Veridien Corporation For more information about Veridien Corporation and its investments in future technology, please visit: and . SOURCE: Veridien Corporation
Veridien Corporation, LargoCheryl Ballou, 727-576-1600 x202
